| Overview |
| Tour d’Horizon of Recent Advances in RUNX Family Gene Research |
| Suk-Chul Bae |
| Mol. Cells 2020; 43(2): 97~98 |
 PDF  PubMed  Google Scholar Search |
|
| Minireviews |
| Role of RUNX Family Transcription Factors in DNA Damage Response |
| Ann Sanoji Samarakkody, Nah-Young Shin, and Alan B. Cantor |
| Mol. Cells 2020; 43(2): 99~106 |
| PDF PubMed Google Scholar Search |
|
| The Roles of RUNX Family Proteins in Development of Immune Cells |
| Wooseok Seo and Ichiro Taniuchi |
| Mol. Cells 2020; 43(2): 107~113 |
| PDF PubMed Google Scholar Search |
|
| The Role of Lozenge in Drosophila Hematopoiesis |
| Ferdinand Koranteng, Nuri Cha, Mingyu Shin, and Jiwon Shim |
| Mol. Cells 2020; 43(2): 114~120 |
| PDF PubMed Google Scholar Search |
|
| The RUNX1 Enhancer Element eR1: A Versatile Marker for Adult Stem Cells |
| Linda Shyue Huey Chuang, Motomi Osato, and Yoshiaki Ito |
| Mol. Cells 2020; 43(2): 121~125 |
| PDF PubMed Google Scholar Search |
|
| RUNX1 Dosage in Development and Cancer |
| Michael Lie-a-ling, Renaud Mevel, Rahima Patel, Karen Blyth, Esther Baena, Valerie Kouskoff, and Georges Lacaud |
| Mol. Cells 2020; 43(2): 126~138 |
| PDF PubMed Google Scholar Search |
|
| RUNX1 Mutations in the Leukemic Progression of Severe Congenital Neutropenia |
| Patricia A. Olofsen and Ivo P. Touw |
| Mol. Cells 2020; 43(2): 139~144 |
| PDF PubMed Google Scholar Search |
|
| The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies |
| Asumi Yokota, Li Huo, Fengli Lan, Jianqiang Wu, and Gang Huang |
| Mol. Cells 2020; 43(2): 145~152 |
| PDF PubMed Google Scholar Search |
|
| The Role of RUNX1 in NF1-Related Tumors and Blood Disorders |
| Youjin Na, Gang Huang, and Jianqiang Wu |
| Mol. Cells 2020; 43(2): 153~159 |
| PDF PubMed Google Scholar Search |
|
| Post-Translational Regulations of Transcriptional Activity of RUNX2 |
| Hyun-Jung Kim, Woo-Jin Kim, and Hyun-Mo Ryoo |
| Mol. Cells 2020; 43(2): 160~167 |
| PDF PubMed Google Scholar Search |
|
| Molecular Mechanism of Runx2-Dependent Bone Development |
| Toshihisa Komori |
| Mol. Cells 2020; 43(2): 168~175 |
| PDF PubMed Google Scholar Search |
|
| Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation |
| Yuki Date and Kosei Ito |
| Mol. Cells 2020; 43(2): 176~181 |
| PDF PubMed Google Scholar Search |
|
| Role of RUNX Family Members in G1 Restriction-Point Regulation |
| Jung-Won Lee and Suk-Chul Bae |
| Mol. Cells 2020; 43(2): 182~187 |
| PDF PubMed Google Scholar Search |
|
| Complex Interplay between the RUNX Transcription Factors and Wnt/β-Catenin Pathway in Cancer: A Tango in the Night |
| Kerri Sweeney, Ewan R. Cameron, and Karen Blyth |
| Mol. Cells 2020; 43(2): 188~197 |
| PDF PubMed Google Scholar Search |
|
| CROX (Cluster Regulation of RUNX) as a Potential Novel Therapeutic Approach |
| Yasuhiko Kamikubo |
| Mol. Cells 2020; 43(2): 198~202 |
| PDF PubMed Google Scholar Search |
|
학회소식
